Top 5 Gut Health Test Solutions in 2026
We rank ZOE (8.9/10), Viome (8.5/10), BIOHM (8.1/10), Floré (7.8/10), then Tiny Health (7.4/10). ZOE couples shotgun sequencing with cohort publications and app coaching, Viome pushes RNA scoring amid skeptical reviews, BIOHM blends bacterial and fungal DNA at mid-tier pricing, Floré ties sequencing to custom probiotics, and Tiny Health specializes in pregnancy and infant sampling.
How we ranked
January 2025 through May 2026 evidence spans Reddit skeptic threads, Consumer Reports screening cautions, Wired kit reporting, cohort summaries in Nature, ZOE education on Facebook, ZOE on X, TechCrunch financing notes, kit comparisons on Gut Reviews, and essay-style nuance on Substack.
- Assay depth and lab rigor (0.30) — Shotgun metagenomics, accredited processing, and published validation outweigh novelty panels because microbiome commerce still races ahead of clinical consensus.
- Report clarity and coaching (0.25) — Readable microbiome storytelling plus structured food or supplement guidance matters more than raw species laundry lists for buyers funding repeat kits.
- Price and subscription value (0.20) — Hardware shipping, retesting cadence, app subscriptions, and bundled supplements determine whether results justify recurring spend versus one-off curiosity.
- Transparency about limits (0.15) — Brands that spell out what stool tests cannot diagnose earn trust when headline promises elsewhere imply faux precision.
- Community sentiment (forums and reviews) (0.10) — Reddit gripe patterns, Trustpilot drift, and mainstream reviews settle ties once laboratory specs look similar on paper.
The Top 5
#1ZOE8.9/10
Verdict: The strongest blend of shotgun microbiome sequencing, large cohort publications, and an always-on nutrition app for buyers who accept membership economics.
Pros
- Research releases such as the Nature microbiome ranking paper tie marketing claims to peer-reviewed cohort statistics rather than vibes alone.
- Public explainers on shotgun sequencing versus older 16S panels give curious customers vocabulary to compare competitors honestly.
- Retail critics including Which? document September 2025 pricing resets that made bundles materially cheaper than legacy launch pricing.
Cons
- Program friction remains high because food logging and coaching prompts demand discipline beyond mailing a swab.
- Independent nutrition writers still question whether personalised scoring beats general Mediterranean-style guidance, as The Oxford Scientist rehearses when interrogating precision nutrition startups.
Best for: Adults who want metagenomic depth, ongoing app coaching, and citations they can share with skeptical clinicians or partners.
Evidence: The Nature cohort article plus Consumer Reports guidance ground ZOE in published data and honest screening limits, while Which? covers bundling economics after the 2025 trim.
Links
- Official site: zoe.com
- Pricing: Gut health test plans
- Reddit: Microbiome scam skepticism thread referencing category economics
- TrustRadius: ZOE competitor landscape
#2Viome8.5/10
Verdict: A breadth-first RNA-powered stack for buyers who want oral plus gut signals and accept aggressive supplement upsells.
Pros
- Metatranscriptomic positioning claims finer functional insight than DNA-only kits, echoing shootout commentary on Gut Reviews.
- CLIA-lab language on official pages reassures buyers comparing boutique mail-in startups.
- CancerDetect and oral health SKUs extend the brand beyond a single stool story for households consolidating wellness vendors.
Cons
- Wired penalised clarity and supplement pricing transparency in its long-form kit review.
- Healthline editors withheld recommendation after vetting, citing limited peer-reviewed validation for personalised supplement formulas.
Best for: Data-comfortable adults who enjoy dense dashboards and already tolerate subscription supplement workflows.
Evidence: Investigative tone from Wired and consumer-medical caution from Healthline frame Viome as technically ambitious yet commercially polarising. Parallel skeptic threads such as the Reddit microbiome conversation keep repeating the same tension between RNA novelty and commerce.
Links
- Official site: viome.com
- Pricing: Gut Intelligence Test
- Reddit: Microbiome scam skepticism thread
- G2: Viome reviews
#3BIOHM8.1/10
Verdict: The pragmatic pick when bacterial plus fungal DNA profiling must arrive without flagship-brand pricing.
Pros
- Strain-level bacterial and fungal readouts address buyers anxious about yeast-heavy symptom patterns many 16S kits ignore.
- Mid-tier pricing and HSA plus FSA positioning cited by reviewers such as GutHealth.org keep it accessible relative to premium bundles.
- Optional nutritionist consults add human interpretation where barebones PDFs frustrate.
Cons
- Trustpilot sentiment skews negative around turnaround delays and service responsiveness, so plan buffers if labs spike volume.
- Reports stay DNA-centric, so buyers needing RNA-style activity insight still graduate to Viome or ZOE.
Best for: Value shoppers who still want multi-kingdom microbiome coverage before investing in full-stack coaching programs.
Evidence: GutHealth.org translates manufacturer claims into plain English, Gut Reviews positions BIOHM between RNA-first kits and probiotic plays, and Reddit echoes commerce skepticism while sentiment on Trustpilot flags delays.
Links
- Official site: biohmhealth.com
- Pricing: Gut test kit
- Reddit: GI Map interpretation discussion
- TrustRadius: BIOHM browse results
#4Floré7.8/10
Verdict: Best when sequencing exists mainly to justify personalised probiotic formulas rather than standalone insight shopping.
Pros
- Whole-genome style marketing on product pages emphasises deep microbial catalogs feeding customized capsules instead of anonymous benchmark charts.
- Precision manufacturing narratives resonate with buyers fatigued by grocery-store probiotic roulette.
- Accepting uploads from other labs signals pragmatic partnering for shoppers migrating between vendors.
Cons
- Commerce ties sequencing tightly to supplement subscriptions, which triggers the same conflicts-of-interest discomfort reviewers flag industry-wide in Consumer Reports.
- Independent journalism coverage is thinner than for ZOE or Viome, so diligence leans on cross-brand comparisons such as Gut Reviews.
Best for: Supplement-first shoppers who already believe customised formulations beat off-the-shelf bottles.
Evidence: Gut Reviews contrasts Floré with Viome and BIOHM, and Consumer Reports explains why supplement bundles deserve skepticism.
Links
- Official site: flore.com
- Pricing: Flore Gut Health Test
- Reddit: Microbiome scam skepticism thread
- Capterra: Wellness software search hub
#5Tiny Health7.4/10
Verdict: The niche leader when pregnancy, postpartum, or infant stool timing matters more than generic adult benchmarking.
Pros
- Paediatric plus maternal positioning fills a gap left by generalist brands, reinforced by independent walkthroughs such as Good Gear.
- Coaches help caregivers translate diaper-era sampling logistics into plans without assuming adult bathroom habits.
- HSA and FSA eligibility signals anchor pricing conversations for young families already drowning in medical bills.
Cons
- Narrow focus means adults seeking cardiometabolic framing still pair Tiny Health with another vendor or defer to clinicians.
- Booking friction noted in independent reviews requires patience during surge seasons.
Best for: Expecting parents and caregivers tracking infant eczema, antibiotic cascades, or feeding transitions where adult-centric reference ranges mislead.
Evidence: Good Gear and Nucleus document family workflows, while Consumer Reports states why paediatric curiosity still cannot replace paediatricians.
Links
- Official site: tinyhealth.com
- Pricing: Shop tests
- Reddit: Paediatric microbiome chat
- G2: Tiny Health search
Side-by-side comparison
| Criterion (weight) | ZOE | Viome | BIOHM | Floré | Tiny Health |
|---|---|---|---|---|---|
| Assay depth and lab rigor (0.30) | 9.5 | 9.2 | 8.4 | 8.6 | 7.8 |
| Report clarity and coaching (0.25) | 9.0 | 8.5 | 7.9 | 7.6 | 8.4 |
| Price and subscription value (0.20) | 8.5 | 7.8 | 8.8 | 7.5 | 8.0 |
| Transparency about limits (0.15) | 8.7 | 8.0 | 8.3 | 7.5 | 8.2 |
| Community sentiment (forums and reviews) (0.10) | 8.6 | 8.4 | 7.8 | 7.6 | 7.8 |
| Score | 8.9 | 8.5 | 8.1 | 7.8 | 7.4 |
Methodology
Editors mixed Reddit threads, Consumer Reports, Wired, Healthline, TechCrunch, Nature cohort work, Which?, Trustpilot signals, Gut Reviews, and coach narratives from January 2025 through May 2026. Scores use Σ (criterion score × weight) with assay depth top-weighted because marketing still outpaces diagnostic clarity. No vendor sponsored this ranking.
FAQ
Why trust ZOE ahead of Viome if both sell personalised nutrition?
ZOE currently pairs shotgun sequencing narratives with major cohort publications such as the linked Nature paper, whereas Viome still fights reputation drag from harsh kit reviews even though RNA science intrigues engineers.
Is BIOHM accurate if Trustpilot looks ugly?
Accuracy is not reducible to star averages, yet delayed turnaround complaints on Trustpilot are common enough that buyers should pad timelines even though laboratory methods remain informative for bacteria plus fungi.
Should families default to Tiny Health?
Families prioritising infant or maternal contexts should start with Tiny Health, while adults comparing cardiometabolic framing may still prefer ZOE unless the paediatric storyline dominates care planning.
Do these tests replace a gastroenterologist?
No. Consumer Reports reminds readers correlation is not causation, and editors repeat that warning for every kit here.
Sources
Review platforms and consumer watchdogs
- Consumer Reports microbiome screening guidance
- Trustpilot BIOHM reviews
- Which? ZOE review
- G2 Viome reviews